Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors.
Lu W, Xiong H, Chen Y, Wang C, Zhang H, Xu P, Han J, Xiao S, Ding H, Chen Z, Lu T, Wang J, Zhang Y, Yue L, Liu YC, Zhang C, Yang Y, Jiang H, Chen K, Zhou B, Luo C.
Lu W, et al. Among authors: chen z, chen k, chen y.
Bioorg Med Chem. 2018 Nov 1;26(20):5397-5407. doi: 10.1016/j.bmc.2018.07.048. Epub 2018 Jul 27.
Bioorg Med Chem. 2018.
PMID: 30297119